title: The neuroprotective effects of Coccomyxa gloeobotrydiformis on the ischemic stroke in a rat model.
abstract: Stroke is a major cause of mortality and the leading cause of permanent disability. In this study, we adopted the classic middle cerebral artery occlusion(MCAO) stroke model to observe the therapeutic effects of coccomyxa gloeobotrydiformis(CGD) on ischemic stroke, and discuss the underlying mechanisms. Low dose (50 mg/kg.day) and high dose (100 mg/kg.day) concentrations of the drug CGD were intragastrically administrated separately for 8 weeks. Infarct volumes, neurologic deficits and degree of stroke-induced brain edema were measured 24 hours after reperfusion. Furthermore, oxidative stress related factors (SOD and MDA), mitochondrial membrane potential, and apoptosis regulatory factors (mitochondrial Cyt-C, Bcl-2, Bax, and caspase-3) were all investigated in this research. We found that CGD attenuated cerebral infarction, brain edema and neurologic deficits; CGD maintained the mitochondrial membrane potential and decreased mitochondrial swelling. It also prevented oxidative damage by reducing MDA and increasing SOD. In addition, CGD could effectively attenuate apoptosis by restoring the level of mitochondrial Cyt C and regulating the expression of Bcl-2, Bax and caspase 3. These results revealed that CGD has a therapeutic effect on ischemic stroke, possibly by inducing mitochondrial protection and anti-apoptotic mechanisms.
authors: Department of Pathophysiology, College of Basic Medical Science, China Medical University, Shenyang, China.
authors: Luning
authors: L
authors: Sun
authors: Ying
authors: Y
authors: Jin
authors: Liming
authors: L
authors: Dong
authors: Ryo
authors: R
authors: Sumi
authors: Rabita
authors: R
authors: Jahan
authors: Zhi
authors: Z
authors: Li
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000975:Antioxidants / Q000032:analysis / Q000494:pharmacology*; D015153:Blotting, Western; D020520:Brain Infarction / Q000473:pathology / Q000517:prevention & control*; D000460:Chlorophyta / Q000737:chemistry*; D007118:Immunoassay; D008297:Male; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D018696:Neuroprotective Agents / Q000032:analysis / Q000494:pharmacology*; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D015424:Reperfusion; D020521:Stroke / Q000188:drug therapy / Q000517:prevention & control*; D017962:alpha-Linolenic Acid / Q000032:analysis / Q000494:pharmacology*
chemical_list: D000975:Antioxidants; D018696:Neuroprotective Agents; D017962:alpha-Linolenic Acid
keywords: Coccomyxa gloeobotrydiformis (CGD); apoptosis; ischemic stroke; mitochondrion
references: PLoS One. 2013;8(3):e60049
references: 23555879
references: Stroke. 2007 Mar;38(3):1057-62
references: 17272760
references: Arch Intern Med. 2001 Oct 22;161(19):2343-50
references: 11606150
references: J Agric Food Chem. 2012 May 2;60(17):4222-6
references: 22458968
references: Neuropharmacology. 2008 Sep;55(3):310-8
references: 18308346
references: Int J Neurosci. 2013 Feb;123(2):89-92
references: 23005700
references: Stroke. 2007 Mar;38(3):967-73
references: 17272772
references: Stroke. 2007 May;38(5):1655-711
references: 17431204
references: Science. 2005 Oct 14;310(5746):314-7
references: 16224023
references: Stroke. 2008 Jun;39(6):1668-74
references: 18309149
references: Biochem J. 1990 May 15;268(1):153-60
references: 2160810
references: Stroke. 1989 Jan;20(1):84-91
references: 2643202
references: Stroke. 2000 Jan;31(1):193-9
references: 10625737
references: Pharmacol Res. 2010 Mar;61(3):226-33
references: 20036742
references: Acta Neurol Scand. 2013 Sep;128(3):202-12
references: 23560937
references: J Biol Chem. 2013 Feb 15;288(7):4935-46
references: 23283967